SONIA SALAS: Open Payments
NPI 1063636744 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 28 payments from 13 companies in 2025. Trend: 2023 $442 · 2024 $226 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $104 |
| Regeneron Healthcare Solutions, Inc. | 4 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Amgen Inc. | 3 | $63 |
| ABBVIE INC. | 2 | $49 |
| Ionis Pharmaceuticals, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $37 |
| Gilead Sciences, Inc. | 1 | $31 |
| Jubilant HollisterStier LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: DUPIXENT, QULIPTA, Repatha, DAWNZERA, Rhapsido, NUCALA, PREVNAR 20, EVENITY.
Industry payments across CA — which companies pay providers there.
